Monkey bites among US military members, Afghanistan, 2011

Emerging Infectious Diseases

Volumn 18, Issue 10, 2012, Pages 1647-1649

  Mease, Luke E ^a,b   Baker, Katheryn A ^a,c  

^a Bagram Air Field ^*  (Afghanistan)

^b Army Health Clinic   (United States)

^c US Gen Leonard Wood Army Hosp   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; RABIES VACCINE; TETANUS TOXOID; VALACICLOVIR;

ADULT; AFGHANISTAN; ARMY; ARTICLE; BITE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; MACACA MULATTA; MALE; POST EXPOSURE PROPHYLAXIS; RISK; WOUND CARE;

ADULT; AFGHANISTAN; ANIMALS; BITES AND STINGS; FEMALE; HUMANS; MACACA MULATTA; MALE; MILITARY PERSONNEL; UNITED STATES; YOUNG ADULT;

EID: 84866531717     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1810.120419     Document Type: Article

References (13)

1. Armed Forces Health Surveillance Center. Animal bites, active and reserve components, U.S. Armed Forces, 2001-2010. MSMR. 2011;18:12-5.
2. Stevens K, Dehgan A, Karlstetter M, Rawan F, Tawhid MI, Ostrowski S, et al. Large mammals surviving conflict in the eastern forests of Afghanistan. Oryx. 2011;45:265-71. http://dx.doi.org/10.1017/S0030605310000517
3. Abrahamian FM, Goldstein EJ. Microbiology of animal bite wound infections. Clin Microbiol Rev. 2011;24:231-46. http://dx.doi.org/10.1128/CMR.00041-10
4. Estep RD, Messaoudi I, Wong SW. Simian herpesviruses and their risk to humans. Vaccine. 2010;28(Suppl 2):B78-84. http://dx.doi.org/10.1016/j.vaccine.2009.11.026
5. Engel GA, Jones-Engel L, Schillaci MA, Suaryana KG, Putra A, Fuentes A, et al. Human exposure to herpesvirus B-seropositive macaques, Bali, Indonesia. Emerg Infect Dis. 2002;8:789-95. http://dx.doi.org/10.3201/eid0808.010467
6. Ostrowski SR, Leslie MJ, Parrott T, Abelt S, Piercy PE. B-virus from pet macaque monkeys: an emerging threat in the United States? Emerg Infect Dis. 1998;4:117-21. http://dx.doi.org/10.3201/eid0401.980117
7. Centers for Disease Control and Prevention. CDC health information for international travel 2012. The yellow book. Gary W. Brunette, editor. New York: Oxford University Press; 2012.
8. Cohen JI, Davenport DS, Stewart JA, Deitchman S, Hilliard JK, Chapman LE. Recommendations for prevention of and therapy for exposure to B virus (Cercopithecine herpesvirus 1). Clin Infect Dis. 2002;35:1191-203. http://dx.doi.org/10.1086/344754
9. Centers for Disease Control and Prevention Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR Morb Mortal Wkly Rep. 2011;60:13-5.
10. World Health Organization. Rabies vaccines: WHO position paper- recommendations. Vaccine. 2010;28:7140-2. http://dx.doi.org/10.1016/j.vaccine.2010.08.082
11. Centers for Disease Control and Prevention Use of a reduced (4- dose) vaccine schedule for postexposure prophylaxis to prevent human rabies-recommendations of the Advisory Committee on Immunization Practices. Ann Emerg Med. 2010;56:64-7. http://dx.doi.org/10.1016/j.annemergmed.2010.05.020
12. Tregle RW Jr, Loe CL, Earhart RH III, d'Autremont SB. Cercopithecine herpesvirus 1 risk in a child bitten by a bonnet macaque monkey. J Emerg Med. 2011;41:e89-90. http://dx.doi.org/10.1016/j.jemermed.2010.02.011
13. Chretien JP. Protecting service members in war-non-battle morbidity and command responsibility. N Engl J Med. 2012;366:677-9. http://dx.doi.org/10.1056/NEJMp1112981